Ensysce Biosciences Announces Participation in the 34th Annual Roth Conference
SAN DIEGO, Feb. 23, 2022 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
News
Entrada Therapeutics to Participate in Cowen 42nd Annual Health Care Conference
BOSTON, Feb. 23, 2022 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company…
Jounce Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on Wednesday, March 2, 2022
CAMBRIDGE, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage…
Rhythm Pharmaceuticals Announces Promotions within its Executive Leadership Team
BOSTON, Feb. 23, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
aTyr Pharma to Participate in Panel at National Institutes of Health Rare Disease Day®
Panel to take place on Monday, February 28, 2022, at 2:55pm EST / 11:55am PST…
Cyclerion Therapeutics and Ariana Pharma Announce an Artificial Intelligence-driven Precision Medicine Collaboration
Collaboration to identify patient-selection biomarkers for Cyclerion’s investigational therapeutics in neurological and neuropsychiatric diseases associated…
ENA Respiratory and the COPD Foundation Partner to Develop Pan-Antiviral Nasal Spray
— INNA-051 is being developed to stimulate innate immunity and reduce the incidence and severity…
Phase 4 PALADIN Study with ILUVIEN® Published in Peer-Reviewed Journal Ophthalmology
Best corrected visual acuity and central subfield thickness were significantly improved at 36 months ILUVIEN…
22nd Century and KeyGene Achieve Breakthrough in Hemp/Cannabis Plant Transformation
New Capabilities Allow 22nd Century to Accelerate Revenue Streams and Create Higher Value Commercial Lines…
Recce Pharmaceuticals Announces Final Subjects Dosed in Third Cohort of Phase I Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327
Highlights: Final three subjects in cohort three have been intravenously dosed; RECCE® 327 at 500mg…
US Patent Office Grants Patent for COVID-19 Risk Test
MELBOURNE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE,…
Rani Therapeutics Unveils High-Capacity RaniPill™ Device For Oral Delivery of Biologics; Reports Preliminary 2021 Consolidated Financial Results
– Preclinical data demonstrates new RaniPill™ HC (High Capacity) delivered 500%-plus higher payloads than current…
Ayala Pharmaceuticals Announces Completion of Enrollment in Part A of RINGSIDE, a Pivotal Phase 2/3 Study of AL102 in Desmoid Tumors
Interim Results expected mid-2022 REHOVOT, Israel and WILMINGTON, Del., Feb. 23, 2022 (GLOBE NEWSWIRE) —…
Intellia Therapeutics Enters Lease Agreement to Build Manufacturing Facility for its CRISPR-based Therapies
State-of-the-art GMP manufacturing facility to support preclinical through commercial production of Intellia’s investigational therapies New…
Science 37® to Present at the Cowen 42nd Annual Health Care Conference
RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2022 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq:…
Envera Systems Simplifies Network Management With GTT Broadband and EtherVision Portal
GTT solution enables Envera Systems to consolidate providers across 156 sites, improving network efficiency and…
iSIGN Media Announces the Successful Conclusion of Exclusive Rights to Technology Solutions
TORONTO, Feb. 23, 2022 (GLOBE NEWSWIRE) — iSIGN Media Solutions Inc. (“iSIGN” or “Company”) (TSX-V:…
Cover Genius Doubles Number of Policies Sold, Surpassing 10 Million
Global insurtech for embedded insurance hits major milestone following a momentous year of growth as…
Tenable Announces New Product Certification Program
New program will help customers gain professional credibility and maximize value of Tenable’s solutions COLUMBIA,…
Illumio Introduces Managed Service Provider Program to Empower MSPs to Protect Customers with Zero Trust Segmentation
New Program Offers MSPs and MSSPs Specialized Capabilities to Defend Against Cyber Attacks Such as…